Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu First Pharmaceutical Group is a prominent Chinese pharmaceutical company headquartered in Chengdu, Sichuan, with a legacy dating back to 1951. The group specializes in the research, development, manufacturing, and marketing of a diverse range of products, including chemical active pharmaceutical ingredients (APIs), finished dosages, and traditional Chinese medicine (TCM) preparations. Its core therapeutic focuses include cardiovascular health, respiratory diseases, and anti-infectives, with a notable reputation for its sterile injectable products. CFPG maintains several large-scale, GMP-certified manufacturing facilities and continues to invest in generic drug consistency evaluations and the development of innovative formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu First Pharmaceutical Group.